Larvol Delta - Adial-Pharmaceuticals-Conrms-Scheduling-of-Meetings-with-FDA-and-European-Regulatory-Agencies-to-Advance-Clinical-Development-of-AD04-for-Alcohol-Use-Disorder

ondansetron ultra-low dose (AD04) - Adial

https://www.globenewswire.com/news-release/2023/02/21/2612259/26135/en/Adial-Pharmaceuticals-Confirms-Scheduling-of-Meetings-with-FDA-and-European-Regulatory-Agencies-to-Advance-Clinical-Development-of-AD04-for-Alcohol-Use-Disorder.html

Feb 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next